Novartis Pharmaceuticals Corporation v. Xavier Becerra, et al
| Novartis Pharmaceuticals Corporation |
| Robert McKinnon Califf, M.D., in his official capacity as s Commissioner of Food and Drugs, Food and Drug Administration and Xavier Becerra, in his official capacity as Secretary of Health and Human Services |
| MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. |
| 24-5235 |
| October 15, 2024 |
| U.S. Court of Appeals, D.C. Circuit |
| Other Statutory Actions |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 21, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| APPELLANT BRIEF [2086119] filed by Novartis Pharmaceuticals Corporation [Service Date: 11/21/2024 ] Length of Brief: 12,992 Words. [24-5235] (Stetson, Catherine) [Entered: 11/21/2024 10:22 PM] |
| ENTRY OF APPEARANCE [2084973] filed by Catherine E. Stetson and co-counsel Susan M. Cook, Marlan Golden on behalf of Appellant Novartis Pharmaceuticals Corporation. [24-5235] (Stetson, Catherine) [Entered: 11/14/2024 05:15 PM] |
| ENTRY OF APPEARANCE [2084858] filed by Chad Landmon and co-counsel Kendall Gurule on behalf of Appellees MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.. [24-5235] (Gurule, Kendall) [Entered: 11/14/2024 11:30 AM] |
| CERTIFICATE AS TO PARTIES, RULINGS AND RELATED CASES [2084843] filed by MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. [Service Date: 11/14/2024 ] [24-5235] (Landmon, Chad) [Entered: 11/14/2024 10:53 AM] |
| DOCKETING STATEMENT [2084974] filed by Novartis Pharmaceuticals Corporation [Service Date: 11/14/2024 ] [24-5235] (Stetson, Catherine) [Entered: 11/14/2024 05:17 PM] |
| UNDERLYING DECISION IN CASE [2084975] submitted by Novartis Pharmaceuticals Corporation [Service Date: 11/14/2024 ] [24-5235] (Stetson, Catherine) [Entered: 11/14/2024 05:18 PM] |
| CERTIFICATE AS TO PARTIES, RULINGS AND RELATED CASES [2084979] filed by Novartis Pharmaceuticals Corporation [Service Date: 11/14/2024 ] [24-5235] (Stetson, Catherine) [Entered: 11/14/2024 05:25 PM] |
| STATEMENT OF INTENT REGARDING APPENDIX DEFERRAL [2084977] filed by Novartis Pharmaceuticals Corporation [Service Date: 11/14/2024 ] Intent: AppxDeferred [24-5235] (Stetson, Catherine) [Entered: 11/14/2024 05:22 PM] |
| STATEMENT OF ISSUES [2084978] filed by Novartis Pharmaceuticals Corporation [Service Date: 11/14/2024 ] [24-5235] (Stetson, Catherine) [Entered: 11/14/2024 05:24 PM] |
| TRANSCRIPT STATUS REPORT [2084976] filed by Novartis Pharmaceuticals Corporation [Service Date: 11/14/2024 ]. Status of Transcripts: Final - All transcripts needed for the appeal have been completed and received. [24-5235] (Stetson, Catherine) [Entered: 11/14/2024 05:20 PM] |
| ENTRY OF APPEARANCE [2084791] filed by Caroline W. Tan and co-counsel Daniel Tenny on behalf of Appellees Xavier Becerra and Robert McKinnon Califf, M.D.. [24-5235] (Tan, Caroline) [Entered: 11/13/2024 05:32 PM] |
| CERTIFICATE AS TO PARTIES, RULINGS AND RELATED CASES [2084792] filed by Xavier Becerra and Robert McKinnon Califf, M.D. [Service Date: 11/13/2024 ] [24-5235] (Tan, Caroline) [Entered: 11/13/2024 05:36 PM] |
| PER CURIAM ORDER [2083049] filed ORDERED that the motion for leave to file under seal [ # 2071288-2 ] be granted. MSN is directed to file on the public docket a redacted version of the motion for bond within 7 days of the date of this order. It is FURTHER ORDERED that the motions to dismiss No. 24-5186 as moot [ # 2080259-3 ] & [ # 2079988-3 ] be granted. It is FURTHER ORDERED that the motions for bond and to consolidate [2071330-2] & [ # 2080002-2 ] be dismissed as moot. It is FURTHER ORDERED that the motions to lift the stay [ # 2079988-2 ] & [ # 2080259-2 ] be granted and the motion to continue the stay [ # 2080002-2 ] be denied. The stay entered in No. 24-5186 is hereby dissolved. It is FURTHER ORDERED that the following briefing schedule and format will apply in No. 24-5235: APPELLANT Brief due 11/21/2024. FEDERAL APPELLEE Brief due on 01/21/2025. INTERVENOR-APPELLEE Brief due on 01/21/2025. APPELLANT Reply Brief due 02/10/2025. DEFERRED APPENDIX due 02/18/2025. FINAL Briefs due 02/25/2025. Withholding issuance of the mandate in No. 24-5186 (SEE ORDER FOR MORE DETAILS). Before Judges: Henderson, Pillard and Walker. [24-5186, 24-5235] [Entered: 10/31/2024 02:38 PM] |
| ENTRY OF APPEARANCE [2083013] filed by Chad Landmon and co-counsel Suzanne Bassett on behalf of Appellees MSN Laboratories Private Limited and MSN Pharmaceuticals Inc.. [24-5235] (Landmon, Chad) [Entered: 10/31/2024 12:24 PM] |
| REPLY [2082030] filed by Novartis Pharmaceuticals Corporation to response [Service Date: 10/25/2024 by CM/ECF NDA] Length Certification: 718 Words. [24-5235] (Stetson, Catherine) [Entered: 10/25/2024 05:30 PM] |
| REPLY [2082039] filed by Xavier Becerra and Robert McKinnon Califf, M.D. in 24-5186, 24-5235 to response [ # 2081666-2 ] [Service Date: 10/25/2024 by CM/ECF NDA] Length Certification: 2,214 Words. [24-5186, 24-5235] (Tan, Caroline) [Entered: 10/25/2024 08:20 PM] |
| REPLY [2082040] filed by MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited to response [ # 2081666-2 ] [Service Date: 10/25/2024 by CM/ECF NDA] Length Certification: 2,355 Words. [24-5186] (Landmon, Chad) [Entered: 10/25/2024 09:55 PM] |
| RESPONSE IN OPPOSITION [2081671] to motion [ # 2080002-2 ] filed by MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. in 24-5186, 24-5235 [Service Date: 10/23/2024 by CM/ECF NDA] Length Certification: 2.303. [24-5186, 24-5235] (Landmon, Chad) [Entered: 10/23/2024 10:37 PM] |
| RESPONSE IN OPPOSITION [2081666] to motion [ # 2079988-2 ], motion [ # 2079988-3 ], motion [ # 2080259-2 ], motion [ # 2080259-3 ] filed by Novartis Pharmaceuticals Corporation [Service Date: 10/23/2024 by CM/ECF NDA] Length Certification: 1892 Words. [24-5186] (Stetson, Catherine) [Entered: 10/23/2024 07:12 PM] |
| NOTICE [2081547] received from the Clerk of the U.S. District Court to supplement record on appeal [24-5235] [Entered: 10/23/2024 01:18 PM] |
| PER CURIAM ORDER [2080523] filed ORDERED that Novartis file a response to the appellees motions filed in No. 24- 5186 [ # 2079988-2 ], [2071330-2], [ # 2079988-3 ], [ # 2080259-3 ], & [ # 2080259-2 ] by October 23, 2024. Any replies are due by October 25, 2024. It is FURTHER ORDERED that MSN file a response to Novartis motion to consolidate filed in No. 24-5235 [ # 2080002-2 ] by October 23, 2024. Any reply is due by October 25, 2024. Before Judges: Henderson, Pillard and Walker. [24-5186, 24-5235] [Entered: 10/17/2024 04:32 PM] |
| RESPONSE IN OPPOSITION [2080259] to motion to consolidate [ # 2080002-2 ] combined with a MOTION to vacate stay pending appeal, to dismiss case as moot filed by Xavier Becerra and Robert McKinnon Califf, M.D. in 24-5186, 24-5235 [Service Date: 10/16/2024 by CM/ECF NDA] Length Certification: 1,199 Words. [24-5186, 24-5235] (Tan, Caroline) [Entered: 10/16/2024 05:40 PM] |
| NOTICE OF APPEAL [2079996] seeking review of a decision by the U.S. District Court in 1:24-cv-02234-DLF filed by Novartis Pharmaceuticals Corporation. Appeal assigned USCA Case Number: 24-5235. [24-5235] [Entered: 10/15/2024 05:45 PM] |
| CLERK'S ORDER [2079999] filed directing the parties to file initial submissions: APPELLANT docketing statement due 11/14/2024. APPELLANT certificate as to parties due 11/14/2024. APPELLANT statement of issues due 11/14/2024. APPELLANT underlying decision due 11/14/2024. APPELLANT deferred appendix statement due 11/14/2024. APPELLANT entry of appearance due 11/14/2024. APPELLANT transcript status report due 11/14/2024. APPELLANT procedural motions due 11/14/2024. APPELLANT dispositive motions due 12/02/2024. APPELLEE certificate as to parties due 11/14/2024. APPELLEE entry of appearance due 11/14/2024. APPELLEE procedural motions due 11/14/2024. APPELLEE dispositive motions due 12/02/2024. [24-5235] [Entered: 10/15/2024 05:47 PM] |
| MOTION [2080002] to consolidate cases filed by Novartis Pharmaceuticals Corporation (Service Date: 10/15/2024 by CM/ECF NDA) Length Certification: 627 Words. [24-5235] (Stetson, Catherine) [Entered: 10/15/2024 05:58 PM] |
| US CIVIL CASE docketed. [24-5235] [Entered: 10/15/2024 05:39 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
| Search for this case: Novartis Pharmaceuticals Corporation v. Xavier Becerra, et al | |
|---|---|
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Web | [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ] |
| Intervenor: MSN Laboratories Private Limited | |
| Represented By: | Chad A. Landmon |
| Represented By: | Kendall K. Gurule |
| Represented By: | Suzanne Elizabeth Bassett |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Intervenor: MSN Pharmaceuticals Inc. | |
| Represented By: | Chad A. Landmon |
| Represented By: | Kendall K. Gurule |
| Represented By: | Suzanne Elizabeth Bassett |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Defendant: Robert McKinnon Califf, M.D., in his official capacity as s Commissioner of Food and Drugs, Food and Drug Administration | |
| Represented By: | Daniel Tenny |
| Represented By: | Caroline W. Tan |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Defendant: Xavier Becerra, in his official capacity as Secretary of Health and Human Services | |
| Represented By: | Daniel Tenny |
| Represented By: | Caroline W. Tan |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
| Plaintiff: Novartis Pharmaceuticals Corporation | |
| Represented By: | Marlan Golden |
| Represented By: | Susan M. Cook |
| Represented By: | Catherine Emily Stetson Esquire |
| Search News | [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ] |
| Search Finance | [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ] |
| Search Web | [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ] |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
